Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Vehicle Controlled, Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

NCT02016885 is registered in ClinicalTrials.gov with Journey Medical Corporation as lead sponsor.

NCT NCT02016885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02016885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Vehicle Controlled, Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
Lead sponsor
Journey Medical Corporation
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2013
Completion date
September 30, 2014
Enrollment
198 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

hyperhidrosis